Thermo Fisher Scientific Inc.TMO

NYSEHealthcareMeasuring & Controlling Devices, NEC
Price (close)
$678.39
Market cap
$250.8B
P/E
36.0x
Revenue (TTM)
$46.3B
Net income
$7.0B
Dividend yield
0.27%
1-year total return
48.2%
Net margin
15.0%
Revenue growth
7.2%
Debt / equity
0.81x

What Thermo Fisher Scientific Inc. does.

Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. We serve customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

We continuously increase our depth of capabilities across our broad portfolio of innovative products and services and leverage our extensive global channels to address our customers’ needs. We do this through organic investments in research and development, capacity and capabilities and through acquisitions. Our goal is to enable our customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$32.2B$39.2B$44.9B$42.9B$42.9B$44.6B
Net income$6.4B$7.7B$7.0B$6.0B$6.3B$6.7B
Free cash flow$6.8B$6.8B$6.9B$6.9B$7.3B$6.3B

More on TMO.

Figures from Thermo Fisher Scientific Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.